Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 15776 - 15800 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Camptothecin	Investigational	MIR15A	406948	upregulated	Camptothecin results in increased expression of MIR15A mRNA	13q14.2	A21497
Camptothecin	Investigational	MIR34A	407040	upregulated	Camptothecin results in increased expression of MIR34A mRNA	1p36.22	A21497
Camptothecin	Investigational	MRE11	4361	downregulated	Camptothecin results in decreased expression of MRE11 mRNA	11q21	A21496
Camptothecin	Investigational	NCK2	8440	downregulated	Camptothecin results in decreased expression of NCK2 mRNA	2q12.2	A20666
Camptothecin	Investigational	PLK3	1263	upregulated	Camptothecin results in increased expression of PLK3 mRNA	1p34.1	A20666
Camptothecin	Investigational	PRC1	9055	downregulated	Camptothecin results in decreased expression of PRC1 mRNA	15q26.1	A20666
Camptothecin	Investigational	RAD50	10111	downregulated	Camptothecin results in decreased expression of RAD50 mRNA	5q31.1	A21496
Camptothecin	Investigational	RAD51	5888	downregulated	Camptothecin results in decreased expression of RAD51 mRNA	15q15.1	A21498 A21496
Camptothecin	Investigational	SDC1	6382	upregulated	Camptothecin results in increased expression of SDC1 mRNA	2p24.1	A20666
Camptothecin	Investigational	SMPD3	55512	upregulated	Camptothecin results in increased expression of SMPD3 mRNA	16q22.1	A21503
Camptothecin	Investigational	TAP1	6890	upregulated	Camptothecin results in increased expression of TAP1 mRNA	6p21.32	A20666
Camptothecin	Investigational	TAX1BP3	30851	upregulated	Camptothecin results in increased expression of TAX1BP3 mRNA	17p13.2	A20666
Camptothecin	Investigational	THBS1	7057	downregulated	Camptothecin results in decreased expression of THBS1 mRNA	15q14	A21504
Camptothecin	Investigational	TNFSF9	8744	upregulated	Camptothecin results in increased expression of TNFSF9 mRNA	19p13.3	A20666
Camptothecin	Investigational	TP53I3	9540	upregulated	Camptothecin results in increased expression of TP53I3 mRNA	2p23.3	A20666
Camptothecin	Investigational	TP53TG1	11257	upregulated	Camptothecin results in increased expression of TP53TG1 mRNA	7q21.12	A20666
Camptothecin	Investigational	TYMS	7298	upregulated	Camptothecin results in increased expression of TYMS mRNA	18p11.32	A21500
Camptothecin	Investigational	XRCC3	7517	downregulated	Camptothecin results in decreased expression of XRCC3 mRNA	14q32.3	A21496
Candesartan cilexetil	Approved Investigational	CD36	948	upregulated	candesartan results in increased expression of CD36 mRNA	7q21.11	A21505
Cannabidiol	Approved Investigational	ICAM1	3383	upregulated	Cannabidiol results in increased expression of ICAM1 mRNA	19p13.2	A21506
Cannabidiol	Approved Investigational	PPARG	5468	upregulated	Cannabidiol results in increased expression of PPARG mRNA	3p25.2	A21507
Cannabidiol	Approved Investigational	PTGS2	5743	upregulated	Cannabidiol results in increased expression of PTGS2 mRNA	1q31.1	A21507
Cannabidiol	Approved Investigational	SERPINE1	5054	downregulated	Cannabidiol results in decreased expression of SERPINE1 mRNA	7q22.1	A21508
Cannabidiol	Approved Investigational	TIMP1	7076	upregulated	Cannabidiol results in increased expression of TIMP1 mRNA	Xp11.3	A21506
Cantharidin	Approved Investigational	HAMP	57817	downregulated	Cantharidin analog results in decreased expression of HAMP mRNA	19q13.12	A20683

Displaying entries 15776 - 15800 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability